December 15, 2025
Headlines

CustoMED Secures $6M to Put AI-Powered, Surgeon-First Orthopedic Surgery on the Global Map

Editor05 mins

Israeli medtech startup CustoMED has closed a $6 million funding round aimed at scaling its AI-driven, 3D-printed solutions for patient-specific orthopedic surgery. The round brought together strategic investors including Longevity Venture Partners, Varana Capital, Flag Capital, the Israel Innovation Authority, a leading orthopedic implant company, and Avishai Abrahami, co-founder and CEO of Wix. CustoMED’s platform…

Read More

$6.7 Million for the AI Testing Frontier: How TestSprite Plans to Become the Quality Gatekeeper of the AI Coding Boom

Editor07 mins

In a world where AI now writes more code than humans can review, a new kind of infrastructure is quietly emerging — not to create more code, but to trust it. TestSprite, a Seattle-based startup building automated testing agents for AI-generated software, has raised $6.7 million in seed funding, bringing its total capital to $8.1…

Read More

VentureMed Group’s $28 Million Raise Marks a Turning Point for Precision Vessel Preparation

Editor06 mins

In the often-overlooked world of vascular intervention, where small vessels dictate the success of life-sustaining treatments, VentureMed Group is betting that smarter engineering can deliver better outcomes. The Minneapolis-based medical device company has raised $28 million in Series C funding, led by S3 Ventures, with continued participation from Endeavour Vision and other existing backers. The…

Read More
Kunal

$18.2 Million for a Back-Office Revolution: How Arya Health Is Re-engineering Post-Acute Care

Editor06 mins

In an industry long anchored by labour-intensive back-office operations, one company is attempting a system-level rethink. Arya Health today announced a US $18.2 million Series A funding round led by ACME Capital, bringing its total raised capital to US $25 million. Based in New York, Arya Health targets the administrative burden of the post-acute care…

Read More

VeroSkills Raises $5.3M to Revolutionize AI-Powered Blue-Collar Hiring Amid America’s $1 Trillion Labor Shortage

Editor09 mins

In an era defined by widening labour shortages and structural mismatches, the Birmingham‑based startup VeroSkills has quietly emerged with ambition. With a newly announced US $5.3 million funding round led by Yonder Ventures alongside Circadian Ventures and Motivate Ventures, VeroSkills is doubling down on its mission: deploy AI‑driven staffing to meet the looming blue‑collar labour shortfall. According to…

Read More

Valthos Raises $30 Million to Make AI the First Line of Defense Against Biological Threats

Editor04 mins

In a striking intersection of biotechnology and artificial intelligence, Valthos Inc. has emerged from stealth with a $30 million seed financing round—led by the OpenAI Startup Fund, Lux Capital and Founders Fund—to build what it calls the “tech stack for biodefense.” Founded by Kathleen McMahon (previously head of Life Sciences at Palantir Technologies) and Tess…

Read More

Uluu Raises $16 Million to Turn Seaweed into the Next Global Plastic Alternative

Editor07 mins

In a pivotal moment for the materials industry, Australian start-up Uluu has secured AU$16 million in its Series A funding round to build a demonstration facility capable of scaling its seaweed-derived plastic alternative. Headquartered in Perth, Western Australia, the company plans to move from its current 100 kg/year pilot plant to a 10-tonne/year demonstration plant…

Read More

Honey Health Secures $7.8M to Deploy Autonomous AI Agents That Transform Healthcare Back Offices

Editor04 mins

In a healthcare landscape increasingly strained by administrative bottlenecks, Honey Health has closed a $7.8 million seed round led by Pelion Ventures, with participation from Streamlined, Burst Capital, and 8-Bit Capital. The Mountain View-based startup is deploying autonomous AI agent teams that handle complex back-office workflows across electronic health records (EHRs), reducing the operational burden…

Read More
CEO Benny Sørensen, MD, PhD,

Hemab Therapeutics Raises $157 Million to Transform the Future of Rare Bleeding Disorder Care

Editor04 mins

For a biotech world often focused on oncology and gene editing, Hemab Therapeutics has carved out a very different frontier: rare, inherited bleeding disorders that have long gone overlooked. The company has raised $157 million in a Series C round, a multifold oversubscribed financing led by Sofinnova Partners, with participation from a global sovereign wealth…

Read More

Polyembo Secures Fresh Funding to Advance “Scrunchy” — a Minimalist Fix for a Complex Vascular Problem

Editor05 mins

In the quiet corridors of interventional radiology, change is seldom dramatic — but sometimes it’s seismic. That may be the case for Polyembo, the Longmont-Colorado based medical-device startup, which has just closed a fresh round of funding led by a multinational strategic investor. The proceeds are earmarked for advancing its next‐generation vascular embolic systems, including…

Read More